Matches in Wikidata for { <http://www.wikidata.org/entity/Q86122054> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q86122054 description "article scientifique publié en 2013" @default.
- Q86122054 description "artículu científicu espublizáu en marzu de 2013" @default.
- Q86122054 description "im März 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86122054 description "scientific article published on 14 March 2013" @default.
- Q86122054 description "wetenschappelijk artikel" @default.
- Q86122054 description "наукова стаття, опублікована в березні 2013" @default.
- Q86122054 name "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 name "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 type Item @default.
- Q86122054 label "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 label "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 prefLabel "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 prefLabel "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 P1433 Q86122054-529D4989-96A6-4DF1-B9AB-58E5608F8020 @default.
- Q86122054 P1476 Q86122054-9B284F65-411E-4658-8348-82494834717A @default.
- Q86122054 P2093 Q86122054-1342767C-430B-4381-95BA-C5798F5C226F @default.
- Q86122054 P2093 Q86122054-3254178B-F37B-4A1C-A604-BC40508339BC @default.
- Q86122054 P2093 Q86122054-44D20CA5-34DB-49CA-B169-9FA7D2BA0BDD @default.
- Q86122054 P2093 Q86122054-6901B950-73FB-4E44-8549-E554B65A8B60 @default.
- Q86122054 P2093 Q86122054-6BC6CE89-ADC1-483F-98D7-944D650ED4FC @default.
- Q86122054 P2093 Q86122054-743AF800-5FA0-4828-812D-2D6DE22D4B31 @default.
- Q86122054 P2093 Q86122054-79269E60-094D-45F6-A445-FB8123C098E2 @default.
- Q86122054 P2093 Q86122054-BC51038D-BF86-40CE-9CC6-1E065E4FEB1C @default.
- Q86122054 P2093 Q86122054-BE07BD6B-82D9-472B-9E45-FD29CBDA3576 @default.
- Q86122054 P2093 Q86122054-C4025007-B0ED-4664-9DCE-EC26B6836C21 @default.
- Q86122054 P2093 Q86122054-CAD0A5B7-0CCD-410F-9964-CBB3C08CB599 @default.
- Q86122054 P2093 Q86122054-CEBD7C04-93A8-47C7-AF28-12FA46E9B8F2 @default.
- Q86122054 P2860 Q86122054-5FF059CA-CE86-4014-942B-BF174C913D98 @default.
- Q86122054 P304 Q86122054-2806D276-10E4-420F-BDA7-904C8403CFCD @default.
- Q86122054 P31 Q86122054-6DFA1EEB-3429-47F1-95DE-08F816751D51 @default.
- Q86122054 P356 Q86122054-D5268A83-12AB-4E2D-B0E8-3887EE92966D @default.
- Q86122054 P433 Q86122054-1C228522-3F74-4259-BADB-96EFF24ACF99 @default.
- Q86122054 P478 Q86122054-B85012DF-DE7D-4206-A326-723998747696 @default.
- Q86122054 P50 Q86122054-09A76D86-74B4-41BB-A31C-733C3ED023A4 @default.
- Q86122054 P577 Q86122054-8148FF3E-1474-438B-A221-2BA7AEE95E4D @default.
- Q86122054 P698 Q86122054-830C31E8-1E93-40C3-8E33-9976CE3BD36B @default.
- Q86122054 P921 Q86122054-8055E81E-F180-4A18-90EC-2F0A6EBD187E @default.
- Q86122054 P356 JAT.13870 @default.
- Q86122054 P698 23411616 @default.
- Q86122054 P1433 Q26842628 @default.
- Q86122054 P1476 "Rationale, design and baseline characteristics of a study to evaluate effects of candesartan on cardiovascular events after drug-eluting stent implantation in patients with ischemic heart disease" @default.
- Q86122054 P2093 "4C (Canderstan for Prevention of Cardiovascular Events after CYPHER or TAXUS Coronary Stenting) investigators" @default.
- Q86122054 P2093 "Hideki Oka" @default.
- Q86122054 P2093 "Hideki Shimomura" @default.
- Q86122054 P2093 "Kazuo Kimura" @default.
- Q86122054 P2093 "Koichi Kikuta" @default.
- Q86122054 P2093 "Koichi Nakao" @default.
- Q86122054 P2093 "Kunihiko Matsui" @default.
- Q86122054 P2093 "Nobuyasu Yamamoto" @default.
- Q86122054 P2093 "Shuichi Oshima" @default.
- Q86122054 P2093 "Shunichi Koide" @default.
- Q86122054 P2093 "Tomohiro Sakamoto" @default.
- Q86122054 P2093 "Toshiyuki Matsumura" @default.
- Q86122054 P2860 Q38397719 @default.
- Q86122054 P304 "472-480" @default.
- Q86122054 P31 Q13442814 @default.
- Q86122054 P356 "10.5551/JAT.13870" @default.
- Q86122054 P433 "5" @default.
- Q86122054 P478 "20" @default.
- Q86122054 P50 Q114427064 @default.
- Q86122054 P577 "2013-03-14T00:00:00Z" @default.
- Q86122054 P698 "23411616" @default.
- Q86122054 P921 Q844935 @default.